While pathogenic mutations in Tau lower its microtubule binding affinity, it is well-established that hyperphosphorylation of Tau in AD and related Tauopathies is the most common cause for impairments in microtubule binding3. The gene discussed is MAPT; the disease is Alzheimer disease.